« Back to Record
Citation APA

Therasse, P., Mauriac, L., Welnicka-Jaskiewicz, M., Bruning, P., Cufer, T., Bonnefoi, H., Tomiak, E., Pritchard, K., Hamilton, A., Piccart-Gebhart, M., & EORTC Breast Cancer and Early Clinical Studies Groups, (2003). Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study. Journal of clinical oncology, 21(5), 843-850. doi:10.1200/JCO.2003.05.135


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55260

Therasse, P., Mauriac, L., Welnicka-Jaskiewicz, M., Bruning, P., Cufer, T., Bonnefoi, H., Tomiak, E., Pritchard, K., Hamilton, A., Piccart-Gebhart, M., & EORTC Breast Cancer and Early Clinical Studies Groups, (2003). Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study. Journal of clinical oncology, 21(5), 843-850. doi:10.1200/JCO.2003.05.135